ProKidney Corp.

NASDAQ: PROK · Real-Time Price · USD
2.35
-0.07 (-2.89%)
At close: Aug 15, 2025, 3:59 PM
2.37
0.85%
After-hours: Aug 15, 2025, 07:35 PM EDT

ProKidney Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
84.94M 97.81M 99.12M 108.09M 214.51M 84.39M 60.65M 191.39M 243.55M 271.63M 490.25M 506.33M 21.88M 29.8M 20.56M 542.3K 223.54K n/a
Short-Term Investments
209.79M 230.69M 259.17M 298.72M 217.02M 244.61M 302.3M 204.94M 202.57M 192.05M n/a n/a n/a n/a n/a 250M n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 250.37M n/a 250.01M n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 6.91M 5.11M -250.01M 250M 379.67K -4.58M
Receivables
1.77M 1.75M 2.45M 5.1M 2.75M 1.9M 1.38M 714K 8.09M 5.48M n/a n/a n/a n/a n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a n/a n/a n/a 9.37M 11.61M 10.78M n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
27.94M 19.43M 19.45M 1.03M n/a n/a 9K -9.37M 603K 208K 1.38M 158K n/a n/a 25K n/a n/a n/a
Total Current Assets
324.44M 359.66M 395.88M 430.23M 450.26M 340.16M 374.15M 406.42M 466.43M 480.14M 504.72M 519.37M 33.91M 35.25M 27.27M 1.44M 243.14K 4.58M
Property-Plant & Equipment
47.69M 46.4M 45.19M 44.57M 48.9M 47.6M 46.41M 45.33M 17.68M 14.85M 13.06M 12.8M 12.82M 12.78M 12.6M n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a 52K 106K 159K 213K 267K 320K 374K 428K n/a n/a n/a
Total Long-Term Assets
47.69M 46.4M 45.19M 44.57M 48.9M 47.6M 46.41M 45.38M 17.79M 15.01M 13.28M 13.07M 20.04M 18.26M 13.03M 250M 379.67K -4.58M
Total Assets
372.13M 406.06M 441.07M 474.79M 499.16M 387.76M 420.55M 451.81M 484.22M 495.15M 518M 532.44M 53.96M 53.51M 40.3M 251.44M 622.8K n/a
Account Payables
2.44M 3.12M 3.63M 2.85M 2.93M 3.38M 5.1M 4.48M 2.83M 3.8M 3.04M 3.45M 2.51M 2.51M 2.83M 16.96K n/a n/a
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -426K n/a n/a 7.34M n/a n/a n/a
Short-Term Debt
n/a 857K 765K 1.07M 1.03M 1.09M 803K 676K n/a n/a n/a n/a 35M 20M n/a n/a 300K n/a
Other Current Liabilities
28.26M 4.22M 10.69M 7.68M 6.09M 4M 6.72M 3.28M 3.49M 435K n/a n/a 1.73M 958K n/a 2.63M 303.13K n/a
Total Current Liabilities
28.26M 32.81M 36.22M 25.18M 20.59M 19.3M 25.04M 20.99M 24.5M 11.28M 10.87M 9.84M 45.8M 31.91M 12.31M 55.14K 603.13K n/a
Long-Term Debt
3.52M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
903K 764K 748K 772K 568K 568K 568K 522K 494K 426K 278K 309K n/a n/a n/a 6.56M n/a -9.86M
Total Long-Term Liabilities
4.42M 3.28M 3.22M 6.14M 6.21M 5.43M 4.18M 2.63M 2.78M 2.89M 2.18M 2.03M 1.62M 1.43M 1.07M 7.7M n/a -9.86M
Total Liabilities
32.68M 36.08M 39.44M 31.32M 26.8M 24.73M 29.22M 23.62M 27.28M 14.17M 13.06M 11.87M 47.42M 33.34M 13.38M 7.76M 603.13K -9.86M
Total Debt
3.52M 3.37M 3.24M 6.44M 6.67M 5.95M 4.41M 2.79M 2.94M 3.09M 2.4M 2.14M 36.99M 21.76M 1.33M n/a 300K n/a
Common Stock
29K 29K 29K 29K 29K 23K 23K 24K 24K 24K 24K 24K 257.66M 249.16M 188.43M 250M 633.00 n/a
Retained Earnings
-1.23B -1.22B -1.2B -1.18B -1.16B -1.15B -1.14B -1.13B -1.35B -1.62B -1.1B -1.1B -251.13M -229M -161.51M -6.32M -5.33K n/a
Comprehensive Income
n/a 75K 130K 321K -6K -44K 130K -64K -127K -19K n/a 0.00 0.00 n/a n/a n/a n/a 9.86M
Shareholders Equity
339.45M -998.55M -994.95M -979.71M -972.37M -1.1B -1.1B -1.09B -1.32B -1.6B -1.1B -1.1B 6.54M 20.17M 26.92M 243.69M 19.68K 9.86M
Total Investments
n/a 230.69M 259.17M 298.72M 217.02M 244.61M 302.3M 204.94M 202.57M 192.05M n/a n/a 250.37M n/a 250.01M 250M n/a n/a